Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection-Reference-Cited by-同舟云学术

Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection

Published:2016-03-04 Issue:11 Volume:51 Page:1073-1080
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Tsuge Masataka,Hiraga Nobuhiko,Uchida Takuro,Kan Hiromi,Miyaki Eisuke,Masaki Keiichi,Ono Atsushi,Nakahara Takashi,Abe-Chayama Hiromi,Zhang Yizhou,Naswa Makokha Grace,Kawaoka Tomokazu,Miki Daiki,Imamura Michio,Kawakami Yoshiiku,Aikata Hiroshi,Ochi Hidenori,Hayes C. Nelson,Chayama Kazuaki

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s00535-016-1189-x.pdf

Reference35 articles.

1. Bruix J, Llovet JM. Hepatitis B virus and hepatocellular carcinoma. J Hepatol. 2003;39(Suppl 1):S59–63.

2. Conjeevaram HS, Lok AS. Management of chronic hepatitis B. J Hepatol. 2003;38(Suppl 1):S90–103.

3. Lee YS, Suh DJ, Lim YS, et al. Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy. Hepatology. 2006;43:1385–91.

4. Suzuki Y, Kumada H, Ikeda K, et al. Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection. J Hepatol. 1999;30:743–8.

5. Belloni L, Allweiss L, Guerrieri F, et al. IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. J Clin Investig. 2012;122:529–37.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal antibody applications in travel medicine;Tropical Diseases, Travel Medicine and Vaccines;2024-01-15

2. Chimeric antigen receptors of HBV envelope proteins inhibit hepatitis B surface antigen secretion;Gut;2023-11-16

3. Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice;Journal of Hepatology;2023-11

4. Development of a highly potent anti-HBs monoclonal antibody for HBV and HDV therapy: An improvement with unsettled questions;Journal of Hepatology;2023-11

5. The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment;Emerging Microbes & Infections;2023-09-13